Cancer Centers in the News

The following links highlight some of the most up-to-date news from the 26 NCCN Member Institutions. The media coverage below includes major national news outlets, industry magazines, medical journals, and press releases.

The news is listed in reverse chronological order for ease of use.

February 4, 2016
Meditation Eases Pain, Anxiety and Fatigue during Breast Cancer Biopsy (Duke Cancer Institute)

Meditation eases anxiety, fatigue and pain for women undergoing breast cancer biopsies, according to researchers at the Duke Cancer Institute. They also found that music is effective, but to a lesser extent.

Duke Cancer Institute is one of the 26 NCCN Member Institutions. 

>View Article<



February 4, 2016
Prostate Cancer Survivors’ Risk of Heart Disease Studied (Vanderbilt-Ingram Cancer Center)

The 3 million prostate cancer survivors in the United States are likely to die from something other than cancer, thanks to early detection, effective treatment, and the disease’s slow progression.

What survivors need to be more concerned with is heart disease, the most common non-cancer cause of death for men with prostate cancer, according to a paper published this week in Circulation, authored by Vanderbilt physicians.

Vanderbilt-Ingram Cancer Center is one of the 26 NCCN Member Institutions.

>View Article<



February 4, 2016
Renowned Oncologist Dr. Marc Ernstoff to Assume Leadership Roles at UB, Roswell Park (Roswell Park Cancer Institute)

Marc S. Ernstoff, MD, has been appointed professor and chief of the Division of Hematology/Oncology in the Department of Medicine in the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo (UB), and chair of the Department of Medicine and senior vice president of clinical investigation at Roswell Park Cancer Institute (RPCI). Ernstoff also will serve as chief of the Division of Hematology/Oncology at UBMD Internal Medicine, the clinical practice plan of the UB Department of Medicine.

Roswell Park Cancer Institute is one of the 26 NCCN Member Institutions. 

>View Article<



February 3, 2016
Investigating Surgery for Women at High Risk of Breast and Ovarian Cancer (Mayo Clinic Cancer Center)

In a review article published in the Feb. 4 issue of the New England Journal of Medicine, a pair of Mayo Clinic Cancer Center researchers provide an in-depth look at the issues associated with the care of women in families with hereditary breast and ovarian cancer syndrome who have not yet developed cancer themselves. The article addresses optimal risk assessment for breast and ovarian cancers, the usefulness of risk-reducing surgery, side effects of these procedures, alternative strategies for cancer prevention and the best ways to help with the decision-making process.

Mayo Clinic Cancer Center is one of the 26 NCCN Member Institutions. 

>View Article<



February 1, 2016
Shedding New Light on Breast Cancer Metastases (Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance)

A new study by researchers at Fred Hutchinson Cancer Research Center and Johns Hopkins Medical Institute, published in PNAS Early Edition, confirmed that clusters of cancer cells indeed travel together throughout all stages of metastasis. The study also identified the molecular signatures unique to these highly aggressive, roaming tumor clumps, such as the fact that each are led by a gang member that’s fueled by a type of cellular kryptonite: a highly expressed protein called keratin 14.

Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins are two of the 26 NCCN Member Institutions. 

>View Article<



February 1, 2016
Does Radiation Therapy Improve Survival for Women with Ductal Carcinoma in Situ (DCIS)? Yes...and...No. (Dana-Farber/Brigham and Women’s Cancer Center)

Approximately 60,000 patients in the United States will receive a diagnosis of ductal carcinoma in situ (DCIS) in 2016. DCIS is not an invasive form of cancer and the 10-year survival rate for women with DCIS is greater than 98 percent. However, incidence of DCIS has increased dramatically over the last three decades, and being able to determine which women are among the small percentage at higher risk of breast cancer recurrence and mortality could help clinicians and patients tailor treatment to neither over treat nor under treat the disease. Investigators from Brigham and Women’s Hospital (BWH) and the Dana-Farber Cancer Institute have found that a set of easily measurable risk factors can predict the magnitude of survival benefit offered by radiation therapy following breast cancer surgery. Their results appear online in The Journal of Clinical Oncology on Feb. 1.

Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center is one of the 26 NCCN Member Institutions. 

>View Article<



January 29, 2016
Proton Therapy Controls Common Pediatric Brain Tumor with Fewer Long-Term Side Effects (Massachusetts General Hospital Cancer Center)

The use of proton radiotherapy to treat the most common malignant brain tumor in children is as effective as standard photon (x-ray) radiation therapy while causing fewer long-term side effects such as hearing loss and cognitive disorders, according to a study receiving online publication in Lancet Oncology. The paper from a team led by Massachusetts General Hospital (MGH) investigators describes patient outcomes an average of seven years after proton therapy for medulloblastoma, a fast-growing tumor that develops in the cerebellum at the base of the brain. 

Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center is one of the 26 NCCN Member Institutions. 

>View Article<



January 27, 2016
Cancer Centers Urge Increase in HPV Vaccinations

The top cancer centers in the U.S. jointly called for an increase in vaccination against the human papilloma virus, or HPV, saying low uptake of the three-shot regimens amounts to a “public health threat” and a major missed opportunity to prevent a variety of potentially lethal malignancies.

All 26 NCCN Member Institutions were represented within the 69 total NCI-designated cancer centers issuing the statement.

>View Article<



January 26, 2016
Nivolumab Combined with Radiation Therapy May Be New Treatment Option for Patients with Melanoma Brain Metastases, Say Moffitt Cancer Center Researchers

President Jimmy Carter’s battle with metastatic melanoma to the brain has placed increased attention on management of this disease. President Carter was treated with focused stereotactic radiation to the brain and anti-PD-1 therapy. Researchers at Moffitt Cancer Center recently reported the first series of patients treated with this combined modality approach. They found that radiation therapy combined with the immune-targeting drug nivolumab in melanoma patients with brain metastases is safe and improves their survival compared to historical data.

Moffitt Cancer Center is one of the 26 NCCN Member Institutions. 

>View Article<



January 26, 2016
Survival Period for Esophageal Cancer Is Tied to Race and Income

African-American patients with esophageal cancer survive fewer months after diagnosis than white patients, but only if they also have low incomes, according to a new study from Duke Health researchers. Duke Cancer Institute is one of the 26 NCCN Member Institutions.

>View Article<



January 26, 2016
Smoking Lowers Breast Cancer Survival, Study Finds

Women diagnosed with breast cancer who continue to smoke cigarettes are less likely to survive than those who never smoked or those who quit, new research finds. The study was led by researchers at UCSF Helen Diller Family Comprehensive Cancer Center—one of the 26 NCCN Member Institutions. 

>View Article<



January 26, 2016
Smokers Who Quit More Than 15 Years Ago Need Screening

Expanding lung cancer screening to include people who quit smoking more than 15 years ago could detect more cases and further reduce associated mortality, according to a study by Mayo Clinic researchers published in the Journal of Thoracic Oncology. Mayo Clinic Cancer Center is one of the 26 NCCN Member Institutions. 

>View Article<



January 25, 2016
Targeted Axillary Dissection of Lymph Nodes after Chemotherapy Improves Staging Accuracy of Node-Positive Breast Cancer Patients

A new procedure developed by surgeons at The University of Texas MD Anderson Cancer Center improves the accuracy of axillary staging and pathologic evaluation in clinically node-positive breast cancer, and reduces the need for a more invasive procedure with debilitating complications. The University of Texas MD Anderson Cancer Center is one of the 26 NCCN Member Institutions. 

>View Article<